thrombin receptor peptide sfllrnp has been researched along with Astrocytoma, Grade IV in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campanella, R; Caroli, M; Carrabba, G; Cordiglieri, C; Costa, A; Gaudino, C; Guarnaccia, L; La Verde, N; Locatelli, M; Luzzi, S; Mantovani, G; Marfia, G; Navone, SE; Rampini, P; Riboni, L; Trombetta, E | 1 |
1 other study(ies) available for thrombin receptor peptide sfllrnp and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology.
Topics: Adenosine Diphosphate; Adult; Aged; Biomarkers, Tumor; Blood Platelets; Brain Neoplasms; Cells, Cultured; Endothelial Cells; Female; Glioblastoma; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peptide Fragments; Phosphotransferases (Alcohol Group Acceptor); Platelet Membrane Glycoproteins; Prognosis; Sphingosine-1-Phosphate Receptors; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2020 |